- Latest available (Revised)
- Point in Time (22/11/2021)
- Original (As made)
Version Superseded: 11/02/2022
Point in time view as at 22/11/2021.
There are currently no known outstanding effects for the The Health Protection (Coronavirus) (International Travel and Operator Liability) (Scotland) Regulations 2021, PART 5.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
35.—(1) Any of the following—S
(a)a person (“P”) who—
(i)before travelling to the United Kingdom has made arrangements with a provider in the United Kingdom to receive healthcare (or, where P is a child, on whose behalf such arrangements have been made),
(ii)is in possession of written confirmation of the arrangements from the provider,
(iii)has travelled to the United Kingdom to receive that healthcare, and
(iv)is attending a place to receive that healthcare.
(b)a person who—
(i)is accompanying P for the purpose of providing necessary care or support to P in the circumstances referred to in sub-paragraph (1)(a)(iv), or
(ii)is travelling, for the purpose of so accompanying P, directly between the place where they are staying in accordance with regulation 26(2) and either of the places referred to in sub-paragraph (1)(a)(iv), where that person has travelled to the United Kingdom for that purpose and is in possession of the confirmation referred to in sub-paragraph (1)(a)(ii) or a copy of it,
(c)a child who is accompanying P or, where P is a child, any child who is accompanying a person referred to in sub-paragraph (1)(b),
(d)a live donor.
(2) For the purposes of this paragraph—
“healthcare” means all forms of healthcare provided for individuals, whether relating to mental or physical health, including healthcare in connection with giving birth,
“live donor” means a person who—
has travelled to the United Kingdom for the purpose of donation of material which consists of or includes their human cells pursuant to arrangements made with a provider in the United Kingdom before travelling to the United Kingdom and which are to be used by the provider for the purpose of providing healthcare, and
is in possession of written confirmation of the arrangements from the provider, and
“provider” means a provider of healthcare.
Commencement Information
I1Sch. 4 para. 35 in force at 20.9.2021, see reg. 1(2)
36.—(1) A person who has travelled to the United Kingdom for the purpose of transporting material which consists of, or includes, human cells or blood and which is to be used for the provision of healthcare by a healthcare provider.S
(2) For the purposes of sub-paragraph (1)—
“blood” includes blood components, and
“healthcare” has the meaning given in paragraph 35.
Commencement Information
I2Sch. 4 para. 36 in force at 20.9.2021, see reg. 1(2)
37. A person who is an “inspector” within the meaning given in regulation 8(1) of the Human Medicines Regulations 2012 M1 who has travelled to the United Kingdom to undertake activities in relation to their role as such a person.S
Commencement Information
I3Sch. 4 para. 37 in force at 20.9.2021, see reg. 1(2)
Marginal Citations
38.—(1) A person who—S
(a)has travelled to the United Kingdom to—
(i)conduct a clinical trial within the meaning of “conducting a clinical trial” in regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004 M2,
(ii)undertake such activities as are necessary or expedient to prepare for the conduct of a clinical trial, or
(iii)carry out any necessary compliance activity in relation to a clinical trial that cannot be conducted remotely,
(b)is a “qualified person” within the meaning of regulation 43 of those Regulations, where they have travelled to the United Kingdom in order to undertake activities in relation to their role as such a person, or
(c)is a “sponsor” within the meaning given in regulation 2(1) of those Regulations, or carries out the functions or duties of a sponsor, of a clinical trial and has travelled to the United Kingdom to undertake activities in relation to a clinical trial.
(2) For the purposes of sub-paragraph (1), “clinical trial” has the meaning given in regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004.
Commencement Information
I4Sch. 4 para. 38 in force at 20.9.2021, see reg. 1(2)
Marginal Citations
39. A person who has travelled to the United Kingdom to—S
(a)conduct a clinical investigation within the meaning of the Medical Devices Regulations 2002 M3,
(b)undertake such activities as are necessary or expedient to prepare for the conduct of a clinical investigation, or
(c)carry out any other necessary compliance activity in relation to a clinical investigation that cannot be conducted remotely.
Commencement Information
I5Sch. 4 para. 39 in force at 20.9.2021, see reg. 1(2)
Marginal Citations
40. A person who is—S
(a)a “qualified person” within the meaning of regulation 41(2) of the Human Medicines Regulations 2012,
(b)a “responsible person” within the meaning of regulation 45(1) of those Regulations, where they have travelled to the United Kingdom in order to undertake activities in relation to their role as such a person.
Commencement Information
I6Sch. 4 para. 40 in force at 20.9.2021, see reg. 1(2)
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: